Skip to main content Accessibility help

A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats

  • Christian Kirkedal (a1), Gregers Wegener (a1) (a2), Fabricio Moreira (a3), Sâmia Regiane Lourenco Joca (a1) (a4) and Nico Liebenberg (a1)...



The cannabinoid receptor 1 (CB1) and transient receptor potential cation channel subfamily V member 1 (TRPV1) are proposed to mediate opposite behavioural responses. Their common denominator is the endocannabinoid ligand anandamide (AEA), which is believed to mediate antidepressant-like effect via CB1-R stimulation and depressive-like effect via TRPV1 activation. This is supposed to explain the bell-shaped dose-response curve for anandamide in preclinical models.


We investigated this assumption by administering the dual inhibitor of AEA hydrolysis and TRPV1 activation N-arachidonoyl-serotonin (AA-5HT) into the medial prefrontal cortex of rats. AA-5HT was given in three different doses (0.125, 0.250, 0.500 nmol/0.4 µl/side) and rat behaviour was assessed in the forced swim test.


Our results show significant antidepressant-like effect of AA-5HT (0.250 nmol) but no effects of low or high doses. The effect of 0.250 nmol AA-5HT was partially attenuated when coadministering the inverse CB1-agonist rimonabant (1.6 µg).


A 0.250 nmol of AA-5HT administration into the medial prefrontal cortex induced a significant antidepressant-like effect that was partially attenuated by locally blocking CB1-receptor.


Corresponding author

Christian Kirkedal, Translational Neuropsychiatric Unit, Departments of Clinical Medicine, Aarhus University, 8240, Risskov Denmark. Tel: +45 7847 1100; Fax: +45 7847 1108; E-mail:


Hide All
1. Holtzheimer, PE, Mayberg, HS. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci 2011;34:19.
2. Willner, P, Scheel-Kruger, J, Belzung, C. The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 2013;37(Pt 1):23312371.
3. Mezey, E, Toth, ZE, Cortright, DN et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000;97:36553660.
4. Tsou, K, Brown, S, Sanudo-Pena, MC, Mackie, K, Walker, JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998;83:393411.
5. Gobbi, G, Bambico, FR, Mangieri, R et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 2005;102:1862018625.
6. Bambico, FR, Duranti, A, Nobrega, JN, Gobbi, G. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin 1A and serotonin 2A/C activity in the hippocampus. Eur Neuropsychopharmacol 2016;26.
7. McLaughlin, RJ, Hill, MN, Gorzalka, BB. A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. Neurosci Biobehav Rev 2014;42:116131.
8. Rubino, T, Realini, N, Castiglioni, C et al. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 2008;18:12921301.
9. Abdelhamid, RE, Kovács, KJ, Nunez, MG, Larson, AA. Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors. Pharmacol Res 2014;79:2127.
10. Manna, SSS, Umathe, SN. A possible participation of transient receptor potential vanilloid type 1 channels in the antidepressant effect of fluoxetine. Eur J Pharmacol 2012;685:8190.
11. Micale, V, Cristino, L, Tamburella, A et al. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 2009;34:593606.
12. You, I-J, Jung, Y-H, Kim, M-J et al. Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT1A, GABAA, and NMDA receptors. Neuropharmacology 2012;62:10341043.
13. Marsch, R, Foeller, E, Rammes, G et al. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 2007;27:832839.
14. Hillard, CJ. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat 2000;61:318.
15. Toth, A, Blumberg, PM, Boczan, J. Anandamide and the vanilloid receptor (TRPV1). Vitam Horm 2009;81:389419.
16. John, CS, Currie, PJ. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze. Behav Brain Res 2012;233:382388.
17. Bambico, FR, Katz, N, Debonnel, G, Gobbi, G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 2007;27:1170011711.
18. Paxinos, G, Watson, C. The rat brain, 7th edn. London, UK: Elsevier Inc, 2015.
19. Cryan, JF, Markou, A, Lucki, I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002;23:238245.
20. Sartim, AG, Moreira, FA, Joca, SRL. Involvement of CB1 and TRPV1 receptors located in the ventral medial prefrontal cortex in the control of depressive-like behavior of rats submitted to the forced swimming test. Presented as a poster October 19th at Society of Neuroscience 2015, Chicago.
21. Navarria, A, Tamburella, A, Iannotti, FA et al. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. Pharmacol Res 2014;87:151159.
22. Kano, M. Control of synaptic function by endocannabinoid-mediated retrograde signaling. Proc Jpn Acad Ser B Phys Biol Sci 2014;90:235250.
23. Steiner, MA, Marsicano, G, Wotjak, CT, Lutz, B. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 2008;33:11651170.


A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats

  • Christian Kirkedal (a1), Gregers Wegener (a1) (a2), Fabricio Moreira (a3), Sâmia Regiane Lourenco Joca (a1) (a4) and Nico Liebenberg (a1)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed